Orgenesis CEO to Participate in Diabetes Panel at

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Orgenesis CEO to Participate in Diabetes Panel at BIO-Europe 2015

GERMANTOWN, MD--(Marketwired - Oct 30, 2015) - Vered Caplan, Chairperson and CEO of Orgenesis ( OTCQB : ORGS ), has been invited to speak on a panel at BIO-Europe 2015 in Munich, Germany. The discussion panel is titled "Focus on Diabetes" and will center on the current landscape, recent developments and trends in the field.

Karin Hehenberger, MD, PhD, a leading expert in the diabetes world, will moderate the panel. Hehenberger is the Founder and CEO of Lyfebulb, which is a patient-centric organization whose mission is to improve the quality of life for people living with chronic disease now.

Industry leaders have been selected to participate with Caplan on the panel. They include: Juliane Bernholz, Lead International Diabetes Partnering, Sanofi; Karin Conde-Knape, Vice President Cardiovascular and Metabolism at Johnson & Johnson Medical; Thomas Landh, Vice President, Senior Principal Scientist Innovation Sourcing, Novo Nordisk; and Brian T. Bloomquist, Senior Director, Diabetes and Endocrine, Global External R&D, Eli Lilly and Company.

"It is an honor to participate on a panel of such high caliber, featuring the companies and individuals who are on the forefront of addressing the research, development and progress on the global effort to better manage and eventually end diabetes," said Vered Caplan, CEO of Orgenesis.

BIO-Europe 2015 will take place Nov. 2-4 at Munich's International Congress Center (ICM) and will include participants spanning the life sciences, pharmaceutical, medical device and technology innovation sectors.

About Orgenesis Inc. Orgenesis is a cell therapy and regenerative medicine company that is committed to developing a cure for Type 1 Diabetes. In pursuit of this goal, the company has developed and patented a novel technology called "cellular trans-differentiation" that turns an insulin-dependent patient's own liver cells into functional insulin producing cells. Orgenesis has proven that, when exposed ex-vivo to certain pancreatic transcription factors and in specific sequence, human adult liver cells can be transformed into fully functional, beta cell-like insulin producing cells (IPCs). After ex-vivo expansion, the IPCs are re-infused via the portal vein of the diabetic patient. In pre-clinical models of Type 1 Diabetes (Non-Obese Diabetic mice), the re-introduced IPCs remain in the liver, effectively respond to glucose challenge and successfully maintain glycemic homeostasis. In the same NOD model, the implanted IPCs were not subject to auto-immune attack or cellular ablation. Orgenesis plans to initiate P1/2 trials in the next 12-18 months. Orgenesis believes that converting the diabetic patient's own tissue into insulin-producing cells has the potential to overcome the significant issues of donor shortage, cost and exposure to chronic immunosuppressive therapy associated with islet cell transplantation. For more information, visit www.orgenesis.com .

Notice Regarding Forward-Looking Statements This news release contains "forward-looking statements" which are not purely historical. Such forward-looking statements include, among other things, the expectations of management that our regeneration technology can be developed as therapeutic treatment for diabetes which could, if successful, be a cure for Type 1 Diabetes; that we can develop the technology to turn a small number of cells into a large number of cells; and that we will initiate Phase I and Phase II clinical trials in the near-term. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits Orgenesis will obtain from them. Actual results could differ from those projected in any forward-looking statements due to numerous factors, including, among others, the potential failure of development candidates to advance through preclinical studies or demonstrate safety and efficacy in clinical testing; the ability to pass clinical trials so as to move on to the next phase; our technology may not as well as expected, our ability to retain key employees; our ability to finance development and operations; our ability to satisfy the rigorous regulatory requirements for new medical procedures; and competitors may develop better or cheaper alternatives to our products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Investors should refer to the risk factors disclosure outlined in our periodic reports filed from time-to-time with the Securities and Exchange Commission.

Media Contact: Tim Rush Springboard5 801-208-1100 tim.rush@springboard5.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 191

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 118

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 261

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 276

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 235

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 258

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 176

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 184

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 47

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 211

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Critical One Progresses on Acquisition of Howells Lake Project

Updated Category News Views 157

Critical One Energy Inc. Moves Forward with Howells Lake Acquisition Critical One Energy Inc. (formerly Madison Metals Inc.) has announced its latest strategic initiative: the acquisition of the Howells Lake Antimony Gold Project. This acquisition reflects the company's commitment to expanding its reach within the critical minerals sector, crucial for a sustainable...

Continue Reading
Breg, Inc. Welcomes Steve Ingel as New President Driving Growth

Updated Category News Views 467

Breg, Inc. Announces Promotion of Steve Ingel to President Breg, Inc., a prominent provider of orthopedic bracing and support solutions, has made a significant announcement regarding its leadership. Steve Ingel has been elevated to the role of President, effective immediately. This change reflects the company's strategy to enhance its growth trajectory and fortify its...

Continue Reading
Schwarzkopf® Wins 2025 Product of the Year for Excellence in Hair Care

Updated Category News Views 444

Schwarzkopf® Wins 2025 Product of the Year Award In an impressive recognition, Schwarzkopf® has won the 2025 Product of the Year USA Award for its innovative hair care line. The Schwarzkopf® Keratin Root Permanent Color and Keratin Root Temporary Color & Thickening Spray have emerged as champions in the Beauty category, voted for by 40,000 American shoppers. This...

Continue Reading
Symbotic Honored as a Top Innovator Workplace by Fast Company

Updated Category News Views 65

Symbotic Named to Fast Company’s Best Workplaces for Innovators Symbotic Inc. (Nasdaq: SYM), a pioneer in A.I.-enabled robotics for supply chains, has been ranked No. 58 on Fast Company’s sixth annual Best Workplaces for Innovators list. The honor celebrates organizations where new ideas are encouraged, supported, and moved into action—where innovation isn’t a...

Continue Reading
Growth Surge in Pharmaceutical Water Market to $89.9 Billion

Updated Category News Views 148

Pharmaceutical Water Market on the Rise The pharmaceutical water market is experiencing a robust increase, projected to surpass US$ 89.9 billion, driven by the escalating demand for high-purity water essential for drug manufacturing. Recent evaluations indicate that this sector, valued at approximately US$ 37.1 billion in the past years, is anticipated to expand at a...

Continue Reading